Literature DB >> 2578539

Multiple, heart-cross-reactive epitopes of streptococcal M proteins.

J B Dale, E H Beachey.   

Abstract

We present evidence that a highly purified pepsin extract of type 5 streptococcal M protein (pep M5) contains at least three epitopes that are cross-reactive with sarcolemmal membrane proteins of human myocardium. The tissue-cross-reactive determinants of pep M5 are also partially shared with pep M6 and pep M19. Three rabbits immunized with a single 300 micrograms dose of pep M5 developed significant levels of heart-cross-reactive antibodies, as determined by indirect immunofluorescence tests. All three sera also contained antibodies that cross-reacted with pep M6 and pep M19. The heart tissue--specific antibodies that were eluted from sarcolemmal membranes opsonized types 5, 6, and 19 streptococci, indicating that they were directed against protective M protein epitopes on the surface of virulent organisms. Immunofluorescence inhibition tests, using purified M proteins as soluble inhibitors of heart-cross-reactive antibodies, revealed the number and M protein serotype distribution of the tissue-cross-reactive epitopes. Immunoblot analyses demonstrated the sarcolemmal membrane proteins containing the various cross-reactive antigenic determinants.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578539      PMCID: PMC2187556          DOI: 10.1084/jem.161.1.113

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  20 in total

1.  An immunological cross-reaction between group-A streptococcal cells and human heart tissue.

Authors:  M H KAPLAN; M MEYESERIAN
Journal:  Lancet       Date:  1962-04-07       Impact factor: 79.321

2.  Cross-reaction of group A streptococci and heart tissue: varying serologic specificity of cross-reactive antisera and relation to carrier-hapten specificity.

Authors:  M H Kaplan
Journal:  Transplant Proc       Date:  1969-12       Impact factor: 1.066

3.  Heart-reactive antibody associated with rheumatic fever: characterization and diagnostic significance.

Authors:  J B Zabriskie; K C Hsu; B C Seegal
Journal:  Clin Exp Immunol       Date:  1970-08       Impact factor: 4.330

4.  Type-specific protective immunity evoked by synthetic peptide of Streptococcus pyogenes M protein.

Authors:  E H Beachey; J M Seyer; J B Dale; W A Simpson; A H Kang
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

5.  Repeating covalent structure of streptococcal M protein.

Authors:  E H Beachey; J M Seyer; A H Kang
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

6.  The complete amino acid sequence of a biologically active 197-residue fragment of M protein isolated from type 5 group A streptococci.

Authors:  B N Manjula; A S Acharya; S M Mische; T Fairwell; V A Fischetti
Journal:  J Biol Chem       Date:  1984-03-25       Impact factor: 5.157

7.  Epitope-specific protective immunogenicity of chemically synthesized 13-, 18-, and 23-residue peptide fragments of streptococcal M protein.

Authors:  E H Beachey; A Tartar; J M Seyer; L Chedid
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

8.  Repeating covalent structure and protective immunogenicity of native and synthetic polypeptide fragments of type 24 streptococcal M protein. Mapping of protective and nonprotective epitopes with monoclonal antibodies.

Authors:  E H Beachey; J M Seyer; J B Dale; D L Hasty
Journal:  J Biol Chem       Date:  1983-11-10       Impact factor: 5.157

9.  Protective antigenic determinant of streptococcal M protein shared with sarcolemmal membrane protein of human heart.

Authors:  J B Dale; E H Beachey
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  An immunological relationship between the group. A streptococcus and mammalian muscle.

Authors:  J B Zabriskie; E H Freimer
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  55 in total

1.  A lipid core peptide construct containing a conserved region determinant of the group A streptococcal M protein elicits heterologous opsonic antibodies.

Authors:  Colleen Olive; Michael R Batzloff; Anikó Horváth; Allan Wong; Timothy Clair; Penny Yarwood; Istvan Toth; Michael F Good
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

2.  Immunogenicity of a 26-valent group A streptococcal vaccine.

Authors:  Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard Beall; James B Dale
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

3.  New protective antigen of group A streptococci.

Authors:  J B Dale; E Y Chiang; S Liu; H S Courtney; D L Hasty
Journal:  J Clin Invest       Date:  1999-05       Impact factor: 14.808

Review 4.  Superantigens: biology, immunology, and potential role in disease.

Authors:  C G Drake; B L Kotzin
Journal:  J Clin Immunol       Date:  1992-05       Impact factor: 8.317

5.  Role of M protein in adherence of group A streptococci.

Authors:  M G Caparon; D S Stephens; A Olsén; J R Scott
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

6.  First attack of rheumatic fever in an adult: the case for greater awareness.

Authors:  A J Farrell; G C Zaphiropoulos
Journal:  Ann Rheum Dis       Date:  1990-12       Impact factor: 19.103

Review 7.  Molecular mimicry--hypothesis or reality?

Authors:  N Tsuchiya; R C Williams
Journal:  West J Med       Date:  1992-08

Review 8.  Strategies in the development of vaccines to prevent infections with group A streptococcus.

Authors:  Michael F Good; Michael R Batzloff; Manisha Pandey
Journal:  Hum Vaccin Immunother       Date:  2013-06-28       Impact factor: 3.452

Review 9.  Molecular Mimicry, Autoimmunity, and Infection: The Cross-Reactive Antigens of Group A Streptococci and their Sequelae.

Authors:  Madeleine W Cunningham
Journal:  Microbiol Spectr       Date:  2019-07

10.  Repeat exposure to group A streptococcal M protein exacerbates cardiac damage in a rat model of rheumatic heart disease.

Authors:  Davina Gorton; Suchandan Sikder; Natasha L Williams; Lisa Chilton; Catherine M Rush; Brenda L Govan; Madeleine W Cunningham; Natkunam Ketheesan
Journal:  Autoimmunity       Date:  2016-08-25       Impact factor: 2.815

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.